FAQ

stage IV salivary gland cancer

Known as: Stage IV Major Salivary Gland Cancer, Stage IV Major Salivary Gland Carcinoma AJCC v7, salivary gland cancer, stage IV 
Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2018
0120022018

Related topics

Related topics

9 relations
Epithelial CellsEpitheliumHead and neck structureMajor salivary gland structure
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
stage IV salivary gland cancer
cancer cell
Head and neck structure
Neoplastic Cell
Epithelial Cells
Salivary Glands

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.
BACKGROUND The purpose of this study was to investigate the efficacy and safety of vinorelbine plus cisplatin chemotherapy in… (More)
Is this relevant?
2017
2017
Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases.
OBJECTIVES Recurrent or metastatic salivary gland malignancies (RMSGM) are not suitable for conventional treatment. We report the… (More)
Is this relevant?
2017
2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
BACKGROUND Salivary gland cancers (SGCs) are uncommon and account for less than 5% of all head and neck cancers, but they are… (More)
Is this relevant?
2016
2016
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
BACKGROUND Androgen deprivation therapy has some clinical activity in selected salivary gland cancer histotypes, with androgen… (More)
  • table 1
  • figure 1
  • table 3
Is this relevant?
2015
2015
Phase II study of gefitinib in patients with advanced salivary gland cancers.
BACKGROUND The purpose of this study was to determine the antitumor activity of the epidermal growth factor receptor (EGFR… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
1029pcisplatin + Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (rmsgm): a Final Report on 60 Cases.
 
Is this relevant?
2005
2005
Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.
 
Is this relevant?
2002
2002
Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case report.
BACKGROUND Malignant tumors of the salivary gland are rare entities that are treated primarily by surgical resection. For… (More)
Is this relevant?